Filing Details
- Accession Number:
- 0001209191-18-021645
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-03-26 17:13:51
- Reporting Period:
- 2018-03-23
- Accepted Time:
- 2018-03-26 17:13:51
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1035354 | Eloxx Pharmaceuticals Inc. | ELOX | Services-Commercial Physical & Biological Research (8731) | 841368850 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1595111 | Robert Ward | C/O Eloxx Pharmaceuticals, Inc. 950 Winter Street, 4Th Floor North Waltham MA 02451 | Chief Executive Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2018-03-23 | 10,000 | $8.99 | 10,000 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Billionaire Hedge Funds
